Creative Planning Akebia Therapeutics, Inc. Transaction History

Creative Planning

$103 Billion
Q4 2024

A detailed history of Creative Planning transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 166,303 shares of AKBA stock, worth $332,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,303

Previous 116,172 43.15%

Holding current value

$332,606

Previous $153,000 101.96%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.26 - $2.13 $63,165 - $106,779	50,131 Added 43.15%	166,303 $309,000
Q3 2024 Oct 11, 2024	BUY	$0.94 - $1.55 $5,153 - $8,497	5,482 Added 4.95%	116,172 $153,000
Q4 2023 Feb 14, 2024	BUY	$0.8 - $1.28 $209 - $335	262 Added 0.24%	110,690 $137,000
Q3 2023 Nov 16, 2023	BUY	$0.87 - $1.84 $96,072 - $203,187	110,428 New	110,428 $125,000
Q2 2021 Aug 04, 2021	SELL	$2.83 - $4.2 $41,467 - $61,542	-14,653 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$2.92 - $5.06 $90,517 - $156,854	-30,999 Reduced 67.9%	14,653 $50,000
Q4 2020 Jan 29, 2021	BUY	$2.22 - $3.78 $71,040 - $120,960	32,000 Added 234.4%	45,652 $128,000
Q3 2020 Nov 05, 2020	BUY	$2.39 - $13.08 $1,868 - $10,228	782 Added 6.08%	13,652 $34,000
Q4 2019 Jan 30, 2020	SELL	$3.16 - $6.73 $11,666 - $24,847	-3,692 Reduced 22.29%	12,870 $81,000
Q3 2019 Nov 01, 2019	SELL	$3.55 - $5.4 $1,682 - $2,559	-474 Reduced 2.78%	16,562 $65,000
Q2 2019 Jul 26, 2019	SELL	$4.1 - $8.05 $1,258 - $2,471	-307 Reduced 1.77%	17,036 $82,000
Q1 2019 Apr 24, 2019	SELL	$5.41 - $8.73 $12,145 - $19,598	-2,245 Reduced 11.46%	17,343 $142,000
Q4 2018 Feb 01, 2019	BUY	$5.39 - $9.15 $48,175 - $81,782	8,938 Added 83.92%	19,588 $108,000
Q2 2018 Jul 20, 2018	SELL	$9.15 - $11.34 $143,838 - $178,264	-15,720 Reduced 59.61%	10,650 $106,000
Q1 2018 Apr 18, 2018	BUY	$9.53 - $15.68 $149,811 - $246,489	15,720 Added 147.61%	26,370 $251,000
Q3 2017 Oct 17, 2017	BUY	$13.06 - $19.67 $139,089 - $209,485	10,650	10,650 $209,000

Others Institutions Holding AKBA

# of Institutions

128

Shares Held

63.3M

Call Options Held

50.6K

Put Options Held

203K

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $368M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Akebia Therapeutics, Inc. Transaction History